Improving care for people living with HIV after hospital discharge
HomeLink2: Reducing posthospitalization mortality among people living with HIV through structured home care and nutritional supplementation
This study is looking at a program called HomeLink2 that helps people living with HIV stay healthy after leaving the hospital by providing home care visits and nutrition support, and it’s designed to see if this approach works better than regular care in keeping you on track with your treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11009327 on NIH RePORTER |
What this research studies
This research investigates a program called HomeLink2, which aims to reduce the risk of death among people living with HIV after they leave the hospital. The program includes structured home care visits and nutritional support to address various barriers that prevent patients from adhering to their treatment plans. By comparing this approach to standard care, the study seeks to determine the most effective methods for improving health outcomes. Patients will receive personalized support to help them manage their health and stay on their antiretroviral therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old living with HIV who have recently been hospitalized.
Not a fit: Patients who are not living with HIV or those who are not recently discharged from the hospital may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly lower posthospitalization mortality rates among people living with HIV.
How similar studies have performed: Previous interventions similar to HomeLink have shown promising results in reducing mortality rates, indicating that this approach has potential for success.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Hoffmann, Christopher J — Johns Hopkins University
- Study coordinator: Hoffmann, Christopher J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.